Fig. 2: Optimisation of the NHP direct PBMC MGIA. | npj Vaccines

Fig. 2: Optimisation of the NHP direct PBMC MGIA.

From: A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates

Fig. 2

Samples were collected from 12 Rhesus macaques from Study 2, six of which were naïve unvaccinated controls (green boxes), and six of which received BCG vaccination by the intradermal (ID) route (blue boxes). The MGIA was performed using PBMC from baseline (circles) and 8 weeks post-BCG vaccination (triangles) according to the original ‘in-tube protocol’ co-culturing in 2 ml screw-cap rotating tubes with (a) 1 × 106 PBMC or (b) 5 × 106 PBMC and a BCG inoculum of 500 CFU. Points represent individual animals with the mean of two co-culture replicates (a) or a single co-culture (b). Normalised mycobacterial growth is equal to (log10 CFU of sample – log10 CFU of inoculum control). Boxes indicate the median value with the interquartile range and whiskers indicate the minimum and maximum values. A one-way ANOVA with Sidak’s multiple comparisons test was performed where *p-value < 0.05.

Back to article page